We are live on
!
Find out more
AIC
Argus Investors Counsel Portfolio holdings
AUM
$130M
1-Year Est. Return
37.06%
This Fund
S&P 500
This Quarter
Est. Return
+12.76%
1 Year Est. Return
+37.06%
3 Year Est. Return
+123.69%
5 Year Est. Return
+149.89%
10 Year Est. Return
+466.25%
AUM
$163M
AUM Growth
+$7.15M
(+4.6%)
Cap. Flow
-$8.97M
Cap. Flow
% of AUM
-5.51%
Top 10 Holdings %
Top 10 Hldgs %
27.73%
Holding
114
New
16
Increased
20
Reduced
66
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trane Technologies
TT
|
+$2.02M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$1.39M |
| 3 |
McKesson
MCK
|
+$1.2M |
| 4 |
BondBloxx Bloomberg One Year Target Duration US Treasury ETF
XONE
|
+$955K |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$898K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.57M |
| 2 |
Archer Daniels Midland
ADM
|
+$1.47M |
| 3 |
Union Pacific
UNP
|
+$1.43M |
| 4 |
PayPal
PYPL
|
+$1.18M |
| 5 |
Broadcom
AVGO
|
+$865K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.38% |
| 2 | Financials | 15.18% |
| 3 | Healthcare | 14.94% |
| 4 | Industrials | 13% |
| 5 | Consumer Discretionary | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
TSMC
TSM
$2.19T
| $272K | 0.17% |
1,996
| – | – |
|
102
Norfolk Southern
NSC
$75.2B
| $255K | 0.16% |
1,000
| – | – |
|
103
AbbVie
ABBV
$442B
| $247K | 0.15% |
+1,359
| New | +$234K |
|
104
Merck
MRK
$322B
| $242K | 0.15% |
+1,833
| New | +$226K |
|
105
Ameriprise Financial
AMP
$49.7B
| $234K | 0.14% |
534
-2
| -0.4% | -$801 |
|
106
IBM
IBM
$225B
| $207K | 0.13% |
+1,085
| New | +$198K |
|
107
Coca-Cola
KO
$372B
| $206K | 0.13% |
+3,365
| New | +$202K |
|
|
NVO
108
Novo Nordisk
NVO
$207B
| $204K | 0.12% |
+1,585
| New | +$189K |
|
|
109
Archer Daniels Midland
ADM
$38.8B
| – | – |
-20,315
| Closed | -$1.47M |
|
110
Danaher
DHR
$146B
| – | – |
-2,925
| Closed | -$677K |
|
|
HOLX
111
DELISTED
Hologic
HOLX
| – | – |
-11,935
| Closed | -$853K |
|
112
Lockheed Martin
LMT
$138B
| – | – |
-1,352
| Closed | -$613K |
|
|
113
PayPal
PYPL
$50.5B
| – | – |
-19,150
| Closed | -$1.18M |
|
114
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
| – | – |
-3,391
| Closed | -$334K |
|
Similar funds
NCM
CG
EPCA
WM
ECP
HHGC
TIA
EIM
Argus Investors Counsel's Q1 2024 Portfolio in Review
As of Q1 2024, Argus Investors Counsel held 114 positions worth $163M, up 4.6% from $156M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Argus Investors Counsel withdrew a net $8.97M in Q1 2024, closing 6 positions and reducing 66 holdings. Its most notable exit was Archer Daniels Midland, an estimated $1.47M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Argus Investors Counsel opened a new position in Regeneron Pharmaceuticals worth $1.41M.
- Argus Investors Counsel's largest Q1 2024 buy was Regeneron Pharmaceuticals: 1,465 shares worth $1.41M.
- Argus Investors Counsel added most to Trane Technologies in Q1 2024, an estimated $2.02M increase.
- Argus Investors Counsel's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $3.57M.
- Argus Investors Counsel fully exited Archer Daniels Midland in Q1 2024, selling an estimated $1.47M.
- Argus Investors Counsel's ten largest holdings make up 28% of its $163M portfolio in Q1 2024.
- Argus Investors Counsel opened 16 new positions and closed 6 in Q1 2024.
- Argus Investors Counsel's portfolio value rose 4.6% quarter-over-quarter to $163M.
Based on Argus Investors Counsel's 13F filing for Q1 2024, filed 25 Apr 2024.